Pyrimethamine/dapsone

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Pyrimethamine/dapsone
Combination of
PyrimethamineAntimalarial
DapsoneAntimicrobial
Clinical data
Trade namesMaloprim
Identifiers
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).

Pyrimethamine/dapsone, sold under the brand name Maloprim, is a combination medication used to treat malaria and pneumocystis jiroveci pneumonia.[1][2] It contains a combination of pyrimethamine (Daraprim), an antimalarial, and dapsone, a sulfone. It is especially useful for preventing reactivation of latent infections in immunocompromised adults.[3] However, its use is limited by the possibility of hematologic toxicity.[3]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).